Low minority participation in lupus clinical trials results in a lack of data regarding effectiveness of treatments among populations with the highest incidence, prevalence, and morbidity from the disease.
Learn more about the factors that contribute to lower minority patient access and participation, as well as what can be done to improve the situation in this podcast for healthcare professionals.